|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a |
| Raymond EG; Chen PL; Luoto J |
| Obstetrics and Gynecology. 2004 Mar;103(3):430-439. |
| To estimate and compare the effectiveness and safety of 5 spermicides over 6 and 7 months of use, respectively. |
| The spermicides included 3 gels containing 52.5 mg, 100 mg, and 150 mg of nonoxynol-9 per dose and a film and a |
| suppository, each containing 100 mg of nonoxynol-9 per dose. Women wishing to use only spermicide for |
| contraception for 7 months were randomly assigned to use 1 of the 5 spermicides with emergency contraception |
| backup. Participants were followed up for up to 30 weeks after admission. Of 1,536 women enrolled, 868 (57%) either |
| relied on the spermicide for 6 months or became pregnant. The probability of pregnancy during 6 months of typical |
| use of the spermicide was 22% (95% confidence limits 16%, 28%) in the 52.5-mg gel group, 16% (10%, 21%) in the |
| 100-mg gel group, 14% (9%, 19%) in the 150-mg gel group, 12% (7%, 17%) in the film group, and 10% (6%, 15%) in |
| the suppository group. The pregnancy risk in the 52.5-mg gel group was significantly different (P < .05) from that in |
| either of the other gel groups. The pregnancy risks in the three 100-mg product groups were not significantly different |
| (P = .35). No significant differences among groups were found in the 7-month probability of specified urogenital |
| conditions. The gel with the lowest amount of nonoxynol- 9 was less effective than the 2 higher-dose gels. Among 3 |
| products containing 100 mg of nonoxynol-9, formulation did not significantly affect pregnancy risk. All products were |
| safe. (PubHealth.info Document ID: CONT1T 507-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Contraceptive effectiveness and safety of five nonoxynol-9 |
| spermicides: a randomized trial.", is(are) Raymond EG; Chen PL; Luoto J. The source of this article is "Obstetrics |
| and Gynecology. 2004 Mar;103(3):430-439.". This article was published in 2004 in English language(s). |
| (PubHealth.info® Document ID: CONT1T 507-06. All rights reserved with PubHealth.info) PIN: 507 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |